News & insights

With open enrollment beginning Oct. 15, Prime highlights Medicare offerings that are helping drive greater value and affordability for plan sponsors and patients

Abby Kim, PharmD, BCOP, senior director of oncology, clinical strategy and specialty solutions at Prime Therapeutics, examines the trends payers should watch as cancer care becomes more complex

Greg Myers, vice president of AI strategy at Prime Therapeutics, shares how AI is creating value for healthcare payers — and what it takes to scale it responsibly

Prime Therapeutics, one of the largest US pharmacy benefit managers, aims to shift to upfront drug pricing and away from a complicated rebates-based system that critics say increases patient costs.

George Van Antwerp, senior vice president of product innovation and strategic planning at Prime Therapeutics, shares how healthcare is evolving to anticipate patient needs, reduce friction and balance cost and care